$14.71
▼ -1.9% Today
as of Aug 5, 16:55 ET
Last 30 days
Recent Press Releases & News
Usana Health Sciences Inc (USNA) (Q2 2026) Earnings Call Highlights: Strategic Pivots Amidst ...
USANA Chairman, CEO Kevin Guest Shares 5 Ways to Make Happiness Happen at Work and Home This August
USANA Health Sciences (USNA) Reports Q2 Loss, Lags Revenue Estimates
Overview
52-week range
$17
$38
0% of range
Avg surprise (last 3)
+26.7%
Avg reaction (last 3)
+3.2%
100% positive
Latest IV / EM
76%
EM ±12.7% · $15 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $0.61 | $0.44 | +38.6% | -16.4% | +3.8% | earnings |
| Sat Sep 27, 2025 | Sep 2025 | $-0.36 | — | — | — | — | financials |
| Tue Jul 22, 2025 | Jun/2025 | $0.74 | $0.54 | +37.0% | — | +4.1% | earnings |
| Tue Apr 22, 2025 | Mar/2025 | $0.73 | $0.70 | +4.3% | — | +1.7% | earnings |
| Sat Sep 28, 2024 | Sep 2024 | $0.56 | — | — | — | — | financials |
| Sat Jun 29, 2024 | Jun 2024 | $0.54 | — | — | — | — | financials |
| Sat Mar 30, 2024 | Mar 2024 | $0.86 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.59 | — | — | — | — | financials |
| Sat Jul 1, 2023 | Jul 2023 | $0.89 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Apr 2026 | Jan 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $59M | — | $49M | $50M | $52M | — | $39M | $40M |
| Gross profit | $191M | — | $165M | $186M | $197M | — | $161M | $173M |
| Operating income | $14M | — | $1M | $17M | $16M | — | $16M | $18M |
| Net income | $8M | — | $-7M | $10M | $9M | — | $11M | $10M |
| EPS (diluted) | $0.41 | — | $-0.36 | $0.52 | $0.49 | — | $0.56 | $0.54 |
Balance sheet (quarterly)
| Metric | Apr 2026 | Jan 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $163M | $158M | $145M | $151M | $180M | $182M | $365M | $332M |
| Inventory | $96M | $103M | $91M | $83M | $74M | $70M | $64M | $62M |
| Total current assets | $294M | $288M | $264M | $262M | $281M | $279M | $451M | $419M |
| Total assets | $739M | $743M | $727M | $735M | $747M | $748M | $671M | $631M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $144M | $157M | $145M | $149M | $163M | $162M | — | — |
| Total equity | $544M | $533M | $528M | $531M | $530M | $532M | $533M | $512M |